Pierfrancesco Tassone

Catanzaro, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 219 publications

Clinical outcomes of the chemo-free approach in relapsed/refractory follicular lymphoma: A network meta-analysis.

Clinical outcomes of the chemo-free approach in relapsed/refractory follicular lymphoma: A network meta-analysis.

Journal: British journal of haematology

Published: March 12, 2026

CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer.

CT-based radiomics as a non-invasive virtual biopsy for high PD-L1 expression prediction in non-small cell lung cancer.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: November 01, 2025

UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific Engager.

UMG1 Defines a Targetable Subset of T-Cell Lymphomas and Enables Precision Immunotherapy With a First-in-Class CD3ε Bispecific Engager.

Journal: Hematological oncology

Published: September 24, 2025

PARP1 trapping activates cGAS-STING pathway to induce immunogenic cell death in multiple myeloma.

PARP1 trapping activates cGAS-STING pathway to induce immunogenic cell death in multiple myeloma.

Journal: Cancer cell international

Published: September 10, 2025

CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells.

CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells.

Journal: Cell death discovery

Published: July 30, 2025

CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy.

CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy.

Journal: Cancers

Published: July 19, 2025

Do age and performance status matter? A systematic review and network meta-analysis of immunotherapy studies in untreated advanced/metastatic non-oncogene addicted NSCLC.

Do age and performance status matter? A systematic review and network meta-analysis of immunotherapy studies in untreated advanced/metastatic non-oncogene addicted NSCLC.

Journal: Frontiers in immunology

Published: May 25, 2025

Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma.

Erratum: miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma.

Journal: Molecular therapy. Nucleic acids

Published: April 10, 2025

MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications.

MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 17, 2025

MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications.

MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 17, 2025

Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's Lymphoma.

Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's Lymphoma.

Journal: Journal of clinical medicine

Published: March 16, 2025

Impact of COVID-19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase.

Impact of COVID-19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase.

Journal: Cancer medicine

Published: March 06, 2025

Showing 1-12 of 219

Last Updated: 09/26/2026